On the other hand, although an excessive reduction in BP leads to poor prognosis of HF [40], the additional administration of SGLT2 inhibitors in HF patients reduced systolic BP by approximately 2 mmHg [41] and did not cause an excessive reduction in BP. Here, SLC5A2 is linked to hydrops fetalis.